$14M Study Compares 3 Sleep Apnea Treatments for 47M Americans

Millions of people with sleep apnea face a frustrating guessing game when choosing treatment, but that's about to change.

The University of Arizona just received a $14 million award to conduct the first major head-to-head comparison of the three most common sleep apnea treatments. The study aims to match the right therapy to the right patient, ending years of trial and error for people whose sleep and health hang in the balance.

About 47 million Americans have sleep apnea, a condition where breathing repeatedly stops during sleep. The disorder doesn't just ruin sleep. It increases risks for high blood pressure, heart disease, and dangerous daytime drowsiness that affects work and safety.

Dr. Sairam Parthasarathy, director of the Center for Sleep, Circadian & Neuroscience Research, will lead the five-year clinical trial. His team will compare three treatments: CPAP machines that deliver pressurized air through a mask, dental devices that keep airways open, and a pill combining two medications.

Each treatment has downsides. CPAP masks can irritate skin and cause bloating. Dental devices sometimes trigger jaw pain. The medication may cause insomnia or urinary problems in some patients.

Researchers will enroll 2,400 people with sleep apnea and track them for 12 months across four university sites. They're partnering with patient advocacy groups to ensure diverse participation, measuring everything from daytime alertness to blood pressure to quality of life.

The study will answer crucial questions doctors can't confidently answer today. Does one treatment work better for women versus men? Do certain therapies match specific health conditions or types of sleep apnea?

The Ripple Effect

This research could reshape how 10 to 12 million Americans currently using CPAP therapy approach their care. Recent studies show that people who don't stick with CPAP face higher heart complication risks, making treatment adherence critical.

The findings won't crown one therapy as superior. Instead, they'll give patients and doctors the evidence to make personalized, informed choices based on individual needs and circumstances.

The study brings together sleep medicine experts from Stanford, University of Maryland, and University of Miami. They're also consulting with patients, physicians, insurers including Medicare, and policymakers to ensure the results address real-world treatment decisions.

Better sleep for millions of Americans is finally getting the research attention it deserves.